Invesco Ltd. Has $5.76 Million Stock Position in Vital Farms, Inc. $VITL

Key Points

• Invesco Ltd. reduced its stake in Vital Farms by 17.5%, holding 189,122 shares worth approximately $5.76 million after selling 40,057 shares in the first quarter.
• Vital Farms saw significant institutional interest, with 98.59% of the stock owned by institutional investors and hedge funds, including considerable increases in holdings from various funds during the same quarter.
• Analysts have a positive outlook on Vital Farms, with eleven analysts giving it a "Buy" rating and setting a consensus price target of $48.20, reflecting a series of price increases from multiple financial institutions.

Invesco Ltd. reduced its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 17.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 189,122 shares of the company's stock after selling 40,057 shares during the period. Invesco Ltd. owned about 0.42% of Vital Farms worth $5,763,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of VITL. US Bancorp DE increased its holdings in shares of Vital Farms by 36.2% during the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock worth $59,000 after purchasing an additional 513 shares during the period. CWM LLC increased its holdings in shares of Vital Farms by 43.2% during the first quarter. CWM LLC now owns 2,154 shares of the company's stock worth $66,000 after purchasing an additional 650 shares during the period. Union Bancaire Privee UBP SA bought a new position in shares of Vital Farms during the first quarter worth approximately $112,000. Hanson & Doremus Investment Management bought a new position in shares of Vital Farms during the first quarter worth approximately $130,000. Finally, GAMMA Investing LLC increased its holdings in shares of Vital Farms by 2,059.4% during the first quarter. GAMMA Investing LLC now owns 6,003 shares of the company's stock worth $197,000 after purchasing an additional 5,725 shares during the period. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

VITL has been the topic of several recent research reports. Stifel Nicolaus raised their target price on shares of Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Mizuho lifted their price objective on shares of Vital Farms from $45.00 to $53.00 and gave the company an "outperform" rating in a research note on Monday, August 11th. BMO Capital Markets reissued an "outperform" rating on shares of Vital Farms in a research note on Friday, August 8th. Telsey Advisory Group lifted their price objective on shares of Vital Farms from $46.00 to $50.00 and gave the company an "outperform" rating in a research note on Friday, August 8th. Finally, Lake Street Capital set a $60.00 price objective on shares of Vital Farms and gave the company a "buy" rating in a research note on Friday, August 8th. Eleven analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Vital Farms has an average rating of "Buy" and a consensus price target of $48.20.

Vital Farms Stock Performance

NASDAQ VITL opened at $51.23 on Wednesday. The firm's fifty day moving average price is $40.57 and its two-hundred day moving average price is $35.54. The stock has a market cap of $2.29 billion, a PE ratio of 45.74 and a beta of 0.94. Vital Farms, Inc. has a fifty-two week low of $27.91 and a fifty-two week high of $52.63. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.10 and a current ratio of 2.48.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.09. The firm had revenue of $184.77 million for the quarter, compared to analysts' expectations of $170.28 million. Vital Farms had a net margin of 7.84% and a return on equity of 18.40%. The company's revenue was up 25.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.36 earnings per share. Vital Farms has set its FY 2025 guidance at EPS. On average, equities analysts expect that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.

Insider Activity

In other Vital Farms news, CFO Thilo Wrede sold 1,200 shares of the business's stock in a transaction on Friday, July 11th. The shares were sold at an average price of $38.97, for a total transaction of $46,764.00. Following the sale, the chief financial officer owned 56,187 shares of the company's stock, valued at approximately $2,189,607.39. The trade was a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Stephanie Coon sold 10,005 shares of the business's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $46.15, for a total transaction of $461,730.75. Following the sale, the senior vice president directly owned 45,779 shares in the company, valued at approximately $2,112,700.85. The trade was a 17.94% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 103,901 shares of company stock valued at $4,141,052. 21.30% of the stock is currently owned by insiders.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Want to see what other hedge funds are holding VITL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vital Farms, Inc. (NASDAQ:VITL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.